Rafferty Asset Management, LLC Edwards Lifesciences Corp Transaction History

Rafferty Asset Management, LLC

$26.8 Billion
Q2 2024

A detailed history of Rafferty Asset Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 65,533 shares of EW stock, worth $4.29 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

65,533

Previous 62,593 4.7%

Holding current value

$4.29 Million

Previous $5.98 Million 1.2%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $247,842 - $277,271	2,940 Added 4.7%	65,533 $6.05 Million
Q1 2024 May 13, 2024	BUY	$72.54 - $95.56 $61,586 - $81,130	849 Added 1.38%	62,593 $5.98 Million
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $103,981 - $131,025	-1,685 Reduced 2.66%	61,744 $4.71 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $331,504 - $446,823	4,785 Added 8.16%	63,429 $4.39 Million
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $271,095 - $314,118	3,330 Added 6.02%	58,644 $5.53 Million
Q1 2023 May 11, 2023	BUY	$74.26 - $84.51 $158,248 - $180,090	2,131 Added 4.01%	55,314 $4.58 Million
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $1.37 Million - $1.75 Million	20,054 Added 60.53%	53,183 $3.97 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $1.49 Million - $1.94 Million	18,044 Added 119.62%	33,129 $2.74 Million
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $345,827 - $512,823	-3,998 Reduced 20.95%	15,085 $1.43 Million
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $193,825 - $243,974	-1,901 Reduced 9.06%	19,083 $2.25 Million
Q4 2021 Feb 10, 2022	BUY	$106.37 - $130.68 $118,070 - $145,054	1,110 Added 5.59%	20,984 $2.72 Million
Q3 2021 Nov 10, 2021	BUY	$102.91 - $122.75 $625,281 - $745,829	6,076 Added 44.04%	19,874 $2.25 Million
Q2 2021 Aug 10, 2021	BUY	$83.84 - $104.76 $76,126 - $95,122	908 Added 7.04%	13,798 $1.43 Million
Q1 2021 May 10, 2021	BUY	$78.68 - $90.67 $75,690 - $87,224	962 Added 8.07%	12,890 $1.08 Million
Q4 2020 Feb 10, 2021	SELL	$71.69 - $91.23 $2.2 Million - $2.8 Million	-30,655 Reduced 71.99%	11,928 $1.09 Million
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $690,780 - $898,970	-10,281 Reduced 19.45%	42,583 $3.4 Million
Q2 2020 Aug 07, 2020	BUY	$57.54 - $76.95 $1.93 Million - $2.58 Million	33,509 Added 173.13%	52,864 $3.65 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $719,274 - $1.11 Million	13,724 Added 243.72%	19,355 $3.65 Million
Q4 2019 Feb 10, 2020	BUY	$71.7 - $82.09 $403,742 - $462,248	5,631 New	5,631 $1.31 Million
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $227,947 - $265,724	-6,746 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $244,812 - $261,947	6,746	6,746 $737,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Edwards Lifesciences Corp Transaction History